Large-capacity fully synthetic antibody library molecular discovery platform;
Hybridoma antibody molecular discovery platform;
Bispecific Antibody technology single cell platforms;
ADC technology platform with independent intellectual property
Single B cell sorting ai antibody discovery platform;
Antibody AI discovery platform with advanced technology.
Sungen Biomedical was founded in 2019 which is an innovative drug discovery design and development enterprise incubated by Hotgen Biotech (SH688068), a listed company on the Shanghai Stock Exchange. The co-founder of Sungen Biomedical is Professor Zhiwei Sun, Vice Chairman of China Monoclonal Antibody Industry Committee.
As a biomedical technology company, we will do our best to meet all the needs of customers.
You must be logged in to post a comment.